UniProt ID | IPYR2_HUMAN | |
---|---|---|
UniProt AC | Q9H2U2 | |
Protein Name | Inorganic pyrophosphatase 2, mitochondrial | |
Gene Name | PPA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 334 | |
Subcellular Localization | Mitochondrion . | |
Protein Description | Hydrolyzes inorganic pyrophosphate. [PubMed: 27523597 This activity is essential for correct regulation of mitochondrial membrane potential, and mitochondrial organization and function] | |
Protein Sequence | MSALLRLLRTGAPAAACLRLGTSAGTGSRRAMALYHTEERGQPCSQNYRLFFKNVTGHYISPFHDIPLKVNSKEENGIPMKKARNDEYENLFNMIVEIPRWTNAKMEIATKEPMNPIKQYVKDGKLRYVANIFPYKGYIWNYGTLPQTWEDPHEKDKSTNCFGDNDPIDVCEIGSKILSCGEVIHVKILGILALIDEGETDWKLIAINANDPEASKFHDIDDVKKFKPGYLEATLNWFRLYKVPDGKPENQFAFNGEFKNKAFALEVIKSTHQCWKALLMKKCNGGAINCTNVQISDSPFRCTQEEARSLVESVSSSPNKESNEEEQVWHFLGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | ALLRLLRTGAPAAAC HHHHHHHHCCCHHHH | 37.35 | 20860994 | |
22 | Phosphorylation | AACLRLGTSAGTGSR HHHHHHCCCCCCCCH | 21.72 | 20068231 | |
22 (in isoform 4) | Phosphorylation | - | 21.72 | - | |
22 (in isoform 3) | Phosphorylation | - | 21.72 | - | |
22 | O-linked_Glycosylation | AACLRLGTSAGTGSR HHHHHHCCCCCCCCH | 21.72 | 30379171 | |
23 | Phosphorylation | ACLRLGTSAGTGSRR HHHHHCCCCCCCCHH | 23.93 | 20068231 | |
23 (in isoform 4) | Phosphorylation | - | 23.93 | - | |
23 (in isoform 2) | Phosphorylation | - | 23.93 | 21406692 | |
23 (in isoform 3) | Phosphorylation | - | 23.93 | - | |
23 | O-linked_Glycosylation | ACLRLGTSAGTGSRR HHHHHCCCCCCCCHH | 23.93 | 30379171 | |
26 | Phosphorylation | RLGTSAGTGSRRAMA HHCCCCCCCCHHHHH | 31.53 | 20068231 | |
26 (in isoform 4) | Phosphorylation | - | 31.53 | - | |
26 (in isoform 3) | Phosphorylation | - | 31.53 | - | |
28 | Phosphorylation | GTSAGTGSRRAMALY CCCCCCCCHHHHHHE | 20.59 | 20068231 | |
28 (in isoform 4) | Phosphorylation | - | 20.59 | - | |
28 (in isoform 2) | Phosphorylation | - | 20.59 | 21406692 | |
28 (in isoform 3) | Phosphorylation | - | 20.59 | - | |
28 | O-linked_Glycosylation | GTSAGTGSRRAMALY CCCCCCCCHHHHHHE | 20.59 | 30379171 | |
35 | Phosphorylation | SRRAMALYHTEERGQ CHHHHHHEECHHCCC | 9.35 | 20068231 | |
37 | Phosphorylation | RAMALYHTEERGQPC HHHHHEECHHCCCCC | 26.45 | 20068231 | |
37 (in isoform 4) | Phosphorylation | - | 26.45 | - | |
37 (in isoform 3) | Phosphorylation | - | 26.45 | - | |
45 | Phosphorylation | EERGQPCSQNYRLFF HHCCCCCCCCEEEEE | 28.30 | 20068231 | |
45 (in isoform 4) | Phosphorylation | - | 28.30 | - | |
45 (in isoform 3) | Phosphorylation | - | 28.30 | - | |
48 | Phosphorylation | GQPCSQNYRLFFKNV CCCCCCCEEEEEECC | 10.89 | 20068231 | |
53 | Acetylation | QNYRLFFKNVTGHYI CCEEEEEECCCCEEC | 43.08 | 19608861 | |
53 (in isoform 3) | Acetylation | - | 43.08 | - | |
56 | Phosphorylation | RLFFKNVTGHYISPF EEEEECCCCEECCCC | 27.86 | 28152594 | |
59 | Phosphorylation | FKNVTGHYISPFHDI EECCCCEECCCCCCC | 12.39 | 28152594 | |
59 (in isoform 2) | Phosphorylation | - | 12.39 | 27642862 | |
61 | Phosphorylation | NVTGHYISPFHDIPL CCCCEECCCCCCCCE | 17.85 | 28152594 | |
68 (in isoform 4) | Phosphorylation | - | 11.19 | - | |
69 | Acetylation | PFHDIPLKVNSKEEN CCCCCCEECCCCCCC | 33.73 | 25953088 | |
69 | Malonylation | PFHDIPLKVNSKEEN CCCCCCEECCCCCCC | 33.73 | 26320211 | |
73 | Acetylation | IPLKVNSKEENGIPM CCEECCCCCCCCCCC | 64.94 | 20167786 | |
81 | Acetylation | EENGIPMKKARNDEY CCCCCCCCHHCCHHH | 37.62 | 20167786 | |
81 | Ubiquitination | EENGIPMKKARNDEY CCCCCCCCHHCCHHH | 37.62 | 29967540 | |
95 (in isoform 4) | Acetylation | - | 2.36 | - | |
95 | Acetylation | YENLFNMIVEIPRWT HHHHHHHHHHCHHHC | 2.36 | 19608861 | |
105 | Acetylation | IPRWTNAKMEIATKE CHHHCCCCCEECCCC | 38.85 | 25953088 | |
105 | Malonylation | IPRWTNAKMEIATKE CHHHCCCCCEECCCC | 38.85 | 26320211 | |
105 | Succinylation | IPRWTNAKMEIATKE CHHHCCCCCEECCCC | 38.85 | 23954790 | |
110 (in isoform 4) | Acetylation | - | 41.42 | - | |
110 | Phosphorylation | NAKMEIATKEPMNPI CCCCEECCCCCCCHH | 41.42 | 20068231 | |
110 | Acetylation | NAKMEIATKEPMNPI CCCCEECCCCCCCHH | 41.42 | 19608861 | |
111 | Ubiquitination | AKMEIATKEPMNPIK CCCEECCCCCCCHHH | 51.29 | - | |
111 | Acetylation | AKMEIATKEPMNPIK CCCEECCCCCCCHHH | 51.29 | 26822725 | |
111 | Malonylation | AKMEIATKEPMNPIK CCCEECCCCCCCHHH | 51.29 | 26320211 | |
111 | Succinylation | AKMEIATKEPMNPIK CCCEECCCCCCCHHH | 51.29 | 27452117 | |
114 | Acetylation | EIATKEPMNPIKQYV EECCCCCCCHHHHHH | 11.05 | 19608861 | |
118 | Acetylation | KEPMNPIKQYVKDGK CCCCCHHHHHHHCCC | 36.51 | 25038526 | |
120 | Phosphorylation | PMNPIKQYVKDGKLR CCCHHHHHHHCCCEE | 12.40 | - | |
122 | Acetylation | NPIKQYVKDGKLRYV CHHHHHHHCCCEEEE | 56.69 | 23749302 | |
122 | Ubiquitination | NPIKQYVKDGKLRYV CHHHHHHHCCCEEEE | 56.69 | 29967540 | |
122 | Succinylation | NPIKQYVKDGKLRYV CHHHHHHHCCCEEEE | 56.69 | 23954790 | |
126 (in isoform 2) | Ubiquitination | - | 6.13 | - | |
145 | Ubiquitination | YIWNYGTLPQTWEDP EEEECCCCCCCCCCC | 2.28 | 29967540 | |
147 (in isoform 4) | Phosphorylation | - | 63.46 | - | |
149 (in isoform 4) | Phosphorylation | - | 11.62 | - | |
150 (in isoform 4) | Phosphorylation | - | 66.12 | - | |
151 (in isoform 4) | Phosphorylation | - | 41.22 | - | |
151 | Phosphorylation | TLPQTWEDPHEKDKS CCCCCCCCCCCCCCC | 41.22 | 32142685 | |
154 | Ubiquitination | QTWEDPHEKDKSTNC CCCCCCCCCCCCCCC | 69.23 | 29967540 | |
155 | Acetylation | TWEDPHEKDKSTNCF CCCCCCCCCCCCCCC | 68.38 | 25953088 | |
155 | Ubiquitination | TWEDPHEKDKSTNCF CCCCCCCCCCCCCCC | 68.38 | 29967540 | |
156 (in isoform 4) | Phosphorylation | - | 47.34 | - | |
157 | Ubiquitination | EDPHEKDKSTNCFGD CCCCCCCCCCCCCCC | 70.96 | 29967540 | |
158 | Phosphorylation | DPHEKDKSTNCFGDN CCCCCCCCCCCCCCC | 34.68 | 27703031 | |
159 | Phosphorylation | PHEKDKSTNCFGDND CCCCCCCCCCCCCCC | 41.57 | 29396449 | |
159 | Acetylation | PHEKDKSTNCFGDND CCCCCCCCCCCCCCC | 41.57 | 19608861 | |
174 | Acetylation | PIDVCEIGSKILSCG CCCHHHHHHEECCCC | 10.69 | 19608861 | |
176 | Ubiquitination | DVCEIGSKILSCGEV CHHHHHHEECCCCCC | 42.31 | 29967540 | |
179 | Phosphorylation | EIGSKILSCGEVIHV HHHHEECCCCCCEEE | 24.45 | - | |
180 | S-nitrosocysteine | IGSKILSCGEVIHVK HHHEECCCCCCEEEE | 4.89 | - | |
180 | S-nitrosylation | IGSKILSCGEVIHVK HHHEECCCCCCEEEE | 4.89 | 19483679 | |
187 | Acetylation | CGEVIHVKILGILAL CCCCEEEEEEEHHHC | 20.32 | 19608861 | |
187 (in isoform 3) | Acetylation | - | 20.32 | - | |
195 | Ubiquitination | ILGILALIDEGETDW EEEHHHCEECCCCCE | 3.64 | 29967540 | |
205 (in isoform 3) | Phosphorylation | - | 3.00 | - | |
215 | Phosphorylation | NANDPEASKFHDIDD ECCCHHHHHCCCHHH | 33.90 | 19664994 | |
216 | Acetylation | ANDPEASKFHDIDDV CCCHHHHHCCCHHHH | 54.49 | 19608861 | |
216 | Succinylation | ANDPEASKFHDIDDV CCCHHHHHCCCHHHH | 54.49 | - | |
216 | Succinylation | ANDPEASKFHDIDDV CCCHHHHHCCCHHHH | 54.49 | - | |
216 | Malonylation | ANDPEASKFHDIDDV CCCHHHHHCCCHHHH | 54.49 | 26320211 | |
218 | Ubiquitination | DPEASKFHDIDDVKK CHHHHHCCCHHHHHH | 34.55 | 29967540 | |
224 | Acetylation | FHDIDDVKKFKPGYL CCCHHHHHHCCCCHH | 60.53 | 23236377 | |
224 | Ubiquitination | FHDIDDVKKFKPGYL CCCHHHHHHCCCCHH | 60.53 | 29967540 | |
224 | 2-Hydroxyisobutyrylation | FHDIDDVKKFKPGYL CCCHHHHHHCCCCHH | 60.53 | - | |
224 | Succinylation | FHDIDDVKKFKPGYL CCCHHHHHHCCCCHH | 60.53 | 23954790 | |
225 | Acetylation | HDIDDVKKFKPGYLE CCHHHHHHCCCCHHH | 59.47 | 25953088 | |
230 | Phosphorylation | VKKFKPGYLEATLNW HHHCCCCHHHEEEEE | 15.19 | 20068231 | |
232 (in isoform 3) | Acetylation | - | 30.99 | - | |
232 | Acetylation | KFKPGYLEATLNWFR HCCCCHHHEEEEEEE | 30.99 | 19608861 | |
234 | Phosphorylation | KPGYLEATLNWFRLY CCCHHHEEEEEEEEE | 15.96 | 20068231 | |
241 | Phosphorylation | TLNWFRLYKVPDGKP EEEEEEEEECCCCCC | 12.99 | 28152594 | |
242 | Malonylation | LNWFRLYKVPDGKPE EEEEEEEECCCCCCC | 52.46 | 26320211 | |
247 | Acetylation | LYKVPDGKPENQFAF EEECCCCCCCCCCEE | 57.44 | 25038526 | |
247 (in isoform 3) | Acetylation | - | 57.44 | - | |
247 | Ubiquitination | LYKVPDGKPENQFAF EEECCCCCCCCCCEE | 57.44 | 29967540 | |
247 | Malonylation | LYKVPDGKPENQFAF EEECCCCCCCCCCEE | 57.44 | 26320211 | |
259 | Acetylation | FAFNGEFKNKAFALE CEECCEECCHHHHHH | 53.92 | 25953088 | |
259 | Succinylation | FAFNGEFKNKAFALE CEECCEECCHHHHHH | 53.92 | - | |
259 | Succinylation | FAFNGEFKNKAFALE CEECCEECCHHHHHH | 53.92 | - | |
261 | Acetylation | FNGEFKNKAFALEVI ECCEECCHHHHHHHH | 45.53 | 19608861 | |
261 | Malonylation | FNGEFKNKAFALEVI ECCEECCHHHHHHHH | 45.53 | 26320211 | |
269 | Acetylation | AFALEVIKSTHQCWK HHHHHHHHHHHHHHH | 55.25 | 25038526 | |
276 | Acetylation | KSTHQCWKALLMKKC HHHHHHHHHHHHHHC | 36.46 | 23954790 | |
276 | Malonylation | KSTHQCWKALLMKKC HHHHHHHHHHHHHHC | 36.46 | 26320211 | |
284 (in isoform 3) | Phosphorylation | - | 61.89 | - | |
286 (in isoform 3) | Phosphorylation | - | 14.86 | - | |
287 (in isoform 3) | Phosphorylation | - | 7.39 | - | |
288 (in isoform 3) | Phosphorylation | - | 5.00 | - | |
288 | Phosphorylation | KKCNGGAINCTNVQI HHCCCCCCCCEEEEE | 5.00 | 32142685 | |
291 | Ubiquitination | NGGAINCTNVQISDS CCCCCCCEEEEECCC | 33.66 | 29967540 | |
293 (in isoform 3) | Phosphorylation | - | 2.63 | - | |
298 | Phosphorylation | TNVQISDSPFRCTQE EEEEECCCCCCCCHH | 21.10 | 20230923 | |
309 | Phosphorylation | CTQEEARSLVESVSS CCHHHHHHHHHHHHC | 43.76 | 22115753 | |
313 | Phosphorylation | EARSLVESVSSSPNK HHHHHHHHHHCCCCC | 21.59 | 22167270 | |
315 | Phosphorylation | RSLVESVSSSPNKES HHHHHHHHCCCCCCC | 34.08 | 22167270 | |
316 | Phosphorylation | SLVESVSSSPNKESN HHHHHHHCCCCCCCC | 47.89 | 22167270 | |
317 | Phosphorylation | LVESVSSSPNKESNE HHHHHHCCCCCCCCH | 25.61 | 19664994 | |
320 | Acetylation | SVSSSPNKESNEEEQ HHHCCCCCCCCHHHH | 66.94 | 25038526 | |
320 | Ubiquitination | SVSSSPNKESNEEEQ HHHCCCCCCCCHHHH | 66.94 | 29967540 | |
322 | Phosphorylation | SSSPNKESNEEEQVW HCCCCCCCCHHHHHH | 51.67 | 22167270 | |
330 (in isoform 2) | Phosphorylation | - | 14.81 | 21406692 | |
331 (in isoform 2) | Phosphorylation | - | 5.88 | 21406692 | |
332 (in isoform 2) | Phosphorylation | - | 5.74 | 21406692 | |
334 | Acetylation | QVWHFLGK------- HHHHHHCC------- | 60.35 | 7675607 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IPYR2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IPYR2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IPYR2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-53; LYS-216; LYS-261 ANDLYS-276, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317, AND MASSSPECTROMETRY. |